Summary of Blockbuster Drugs

Looking for the book?
We have the summary! Get the key insights in just 10 minutes.

Blockbuster Drugs book summary
Start getting smarter:
or see our plans

Rating

7 Overall

6 Applicability

8 Innovation

6 Style


Recommendation

Dr. Jie Jack Li offers a fascinating study of the processes and personalities behind “blockbuster drug” – medications with annual sales of more than $1 billion, such as Prilosec, Oxycontin, Claritin and Heparin. He opens with the industry’s eight-year hunt for the first blockbuster – the 1986 ulcer treatment Tagamet – and traces the development of best-selling allergy drugs, blood thinners, acid-blockers and painkillers. Though Li sketches marketing strategies and provides cost and revenue data, his detailed, well-researched account is not aimed at the general business reader. He focuses on science, on the research efforts that produce such drugs and on each drug’s chemical “mechanism of action.” The science-shy or those people who are not up on pharmaceutical jargon may struggle to penetrate the terminology. However, getAbsract recommends this history of the “golden era of drug development” to executives with science backgrounds, as well as to industrial pharmacologists and chemists. Li’s insights will also interest investors and entrepreneurs involved with or curious about the profit-and-loss cycles and scientific dynamics of big pharma.

In this summary, you will learn

  • What a “blockbuster drug” is;
  • What scientific, regulatory and marketing hurdles a new drug faces; and
  • What challenges face the pharma industry.
 

About the Author

Dr. Jie Jack Li teaches organic chemistry and the history of drug discovery at the University of San Francisco. He also wrote Laughing Gas, Viagra, and Lipitor: The Human Stories Behind the Drugs We Use; Triumph of the Heart: The Story of Statins; and Drug Discovery: Practices, Processes and Perspectives with E.J. Corey.

 

Summary

The “Golden Age”

The last half of the 20th century was a peak period for the pharmaceutical industry, an era when “blockbuster drugs” elevated corporate bottom lines and improved the lives of millions of patients. Blockbusters – drugs with more than $1 billion in annual sales – typically offer safe, effective treatments for common conditions such as ulcers, hypertension, high cholesterol, pain, allergies and depression. The first decade of the 21st century was not as successful for the industry. Older drugs’ patents are lapsing, and pharma companies have fewer new drugs in the pipeline.


More on this topic

Customers who read this summary also read

Healthcare Disrupted
Healthcare Disrupted
8
The Poison We Pick
The Poison We Pick
8
The Lawyer Who Beat Big Tobacco Takes on the Opioid Industry
The Lawyer Who Beat Big Tobacco Takes on the Opioid Industry
8
When Evidence Says No, but Doctors Say Yes
When Evidence Says No, but Doctors Say Yes
8
Drugs You Don't Need for Disorders You Don't Have
Drugs You Don't Need for Disorders You Don't Have
9
Demystifying Drug Pricing
Demystifying Drug Pricing
8

Related Channels

Comment on this summary